Exploring the potential of fully automated LUMIPULSE G plasma assays for detecting Alzheimer's disease pathology.

"Declarations Ethics approval and consent to participateThis study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and was approved by the Ethics Board of Coimbra University Hospital (OBS.SF.228–2021). Informed consent was obtained from all subjects involved in the study, or responsible caregivers, whichever was appropriate. Consent for publicationNot applicable. Competing interestsA.N. and N.LB. are employees of Fujirebio S.L. and N.V., respectively. Competing interests A.N. and N.LB. are employees of Fujirebio S.L. and N.V., respectively."

"Funding This work was partially funded by FCT – Fundação para a Ciência e a Tecnologia, I.P., under project EXPL/MEC-NEU/0192/2021, and the COMPETE 2020—Operational Programme for Competitiveness and Internationalization and Portuguese national funds via FCT under project UIDB/04539/2020: CIBB. ASS was supported by FCT (DFA/BD/6393/2020). The funding agency had no role in the study design, sample collection, data analysis, or the writing of the manuscript."